MedTech analysis

U.S. Markets for Biologic and Tissue Engineered Devices – Cardiovascular and Neurological Products

$3,750.00

U.S. Markets for Biologic and Tissue Engineered Devices – Cardiovascular and Neurological Products, March 2015

U.S. Markets for Anesthesia and Ventilation Products, February 2015

A major driver of the U.S. anesthesia delivery systems market is the increase in surgical procedure volumes; this is largely due to the aging of the population, and will continue over the forecast period covered by this report.

February 1, 2015

U.S. Markets for Advanced Wound Care Products

U.S. Markets for Advanced Wound Care Products

U.S. Disease Incidence and Prevalence

This comprehensive report examines the etiology and epidemiology, number of hospital discharges, incidence and prevalence, and mortality rates of the most prevalent diseases/disorders in the United States for the years 2000-2010, and 2013.

November 3, 2014

U.S. Cancer Statistics Update 2014

$1,950.00

This new report from Medtech Insight includes statistics for new cancer cases, prevalence, and deaths due to the disease in 2014.

U.S. Benign Uterine Conditions Therapy Systems Market

$3,750.00

This report presents an overview of the most common types of treatment for the benign uterine conditions of menorrhagia and uterine fibroids/polyps; among these therapies are dilation and curettage, hysterectomy, hysteroscopy, and myomectomy. Market and competitive analyses for the medical devices used in these treatments also are presented.

May 1, 2013

Type 1 Diabetes KOL Interview – US, Midwest

$599.00

This interview with a US Key Opinion Leader (KOL) provides insight into current therapies for type 1 diabetes, as well as pricing pressures within the diabetes market.

January 8, 2020

Type 1 Diabetes KOL Interview – UK

$599.00

This interview with a UK Key Opinion Leader (KOL) provides insight into current therapies for type 1 diabetes.

January 8, 2020

Triple-Negative Breast Cancer KOL Interview – UK

$599.00

A UK-based key opinion leader providers insights into prescribing habits, key marketed brands, and late-phase pipeline therapies for triple- negative breast cancer. Diagnostic testing, biomarker disease segmentation, and unmet needs are also discussed. Key pipeline assets highlighted include balixafortide, Keytruda, sacituzumab govitecan, trastuzumab deruxtecan, and veliparib.

October 31, 2019

Transcatheter Heart Valve Repair and Replacement Devices

In 2020, the global market for transcatheter heart valve management products, including transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve (TMV) repair products, totaled nearly $4.7bn, with TAVR products accounting for nearly 90% of sales.

August 30, 2021

Transcatheter Embolization and Occlusion Devices

This comprehensive medical market and technology report provides an overview and in-depth market analysis of the global market for transcatheter embolization and occlusion devices.

February 25, 2020

The Real Value of Medtech Markets: The impact of currency movements

$2,995.00

This report provides a comprehensive picture of the global medical orthopaedics market and relevant background, using the latest data and expert analysis. The report covers the top 160 markets by estimated US dollar value in 2019.

November 27, 2019

The Global Molecular Diagnostics Market

$6,250.00

The molecular diagnostic products market is the highest growth segment of the global in vitro diagnostics (IVDs) market valued at an estimated $5.3 billion in 2014 and projected to grow at a compound annual growth rate of 6.6% to $7.3 billion by the year 2019.

Surgical Procedure Volumes, US

This report presents the most common surgical procedures performed in the United States (US) as well as an overview of the etiology and epidemiology of selected diseases/disorders, prevailing surgical approaches/techniques, and evolving procedural utilization trends.

December 22, 2016